Literature DB >> 16081349

Cord blood transplantation in adult patients.

W Tse1, Mj Laughlin.   

Abstract

Early clinical reports outlining outcomes for primarily pediatric patients undergoing UCB transplantation point to delayed time to hematopoietic recovery and favorable incidence and severity of GvHD. Recently, clinical reports in adult patients identified the feasibility of UCB transplantation for those patients lacking an available histocompatible-related or unrelated adult donor Intensive clinical and laboratory research is ongoing focused on strategies to foster UCB allogeneic donor engraftment thereby allowing wider application of this stem cell source for patients requiring allogeneic transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 16081349     DOI: 10.1080/14653240510027154

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  4 in total

1.  Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks.

Authors:  T Holmes; F Yan; K-H Ko; R Nordon; E Song; T A O'Brien; A Dolnikov
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

Review 2.  Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

Authors:  Patrick J Hanley; Conrad Russell Cruz; Elizabeth J Shpall; Catherine M Bollard
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

3.  Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.

Authors:  K Mizrahi; S Ash; T Peled; I Yaniv; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

4.  Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.

Authors:  Wen-Ching Shen; Chan-Jung Liang; Vin-Cent Wu; Shu-Huei Wang; Guang-Huar Young; I-Rue Lai; Chung-Liang Chien; Seu-Mei Wang; Kwan-Dun Wu; Yuh-Lien Chen
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.